Nath Bio-Genes (India) Limited is a prominent player in the Indian agricultural sector, specializing in the research, development, production, and marketing of high-quality hybrid seeds. The company's core mission is to develop genetically pure and premium seeds that are tailored to meet the specific requirements of farmers across various agro-climatic conditions. Its product development strategy is deeply rooted in extensive market research to understand farmer needs, with a significant emphasis on creating seeds with strong disease and pest resistance to drive higher yields. The company's primary product focus is on key field crops such as Cotton, Paddy, Maize, Wheat, and Fodder Bajra, complemented by a portfolio of vegetable seeds.

To support its operations, Nath Bio-Genes has built a formidable infrastructure and an extensive distribution network. It operates a network of approximately 20,000 distributors and dealers, supported by 17 branch offices, 10 processing plants, and warehouses spread across 23 states in India. This vast reach ensures its products are accessible to a wide farming community. The company's research and development capabilities are a cornerstone of its business, with a dedicated team of experienced scientists, a large and diverse collection of germplasm, and well-invested, DSIR (Department of Scientific and Industrial Research) recognized R&D innovation centers. These facilities, which include cold storage and conditioning godowns with a capacity of 25,000 metric tons, enable the company to maintain seed quality and drive innovation.

Official Website: http://www.nathbiogenes.com/

• Revenue Performance: The company reported strong top-line growth for the fiscal year ended March 31, 2026. Total revenue stood at ₹4,316 million, a significant 19% increase from ₹3,623 million in FY25. This performance is consistent with its long-term trajectory, having achieved a Compound Annual Growth Rate (CAGR) of 12.5% between FY19 and FY26.

• Profitability Analysis: While revenue grew, profitability metrics showed signs of pressure.

• Gross Profit increased by 5% to ₹2,403 million in FY26.

• EBITDA remained flat year-over-year at ₹525 million.

• Profit After Tax (PAT), adjusted for exceptional items, saw a decline of 8%, falling to ₹384 million in FY26 from ₹416 million in FY25.

• Earnings Per Share (EPS), however, increased by 6% to ₹23.42 from ₹22.00 in the previous year.

• Balance Sheet Health: The company maintains a strong balance sheet.

• Net Worth has consistently grown, reaching ₹6,893 million in FY26.

• Net Debt stood at ₹510 million in FY26. This is an increase from ₹235 million in FY25 but remains at a manageable level relative to net worth and historical figures.

• Working Capital: A notable increase in inventories was observed, rising to ₹4,446 million in FY26 from ₹3,307 million in FY25. Trade Payables also increased significantly to ₹1,305 million from ₹787 million.

The company achieved robust revenue growth in FY26, but this was accompanied by significant margin compression, leading to a decline in net profit despite a healthy balance sheet.

• Integrated R&D and Product Development: The company’s strategy revolves around creating "Tailor Made Products." This involves deep market research to understand farmer needs, followed by developing seeds suited for diverse agro-climatic conditions. A key focus is on breeding for disease and pest resistance, which inherently leads to higher yields.

• Extensive Distribution Network: A primary competitive advantage is its vast supply chain and distribution network. With approximately 20,000 distributors and dealers, 17 branch offices, and 10 processing plants across 23 states, the company has established a deep market penetration that is difficult to replicate.

• Strong R&D Infrastructure: Nath Bio-Genes operates DSIR-recognized R&D centers staffed by experienced scientists. Its large and diverse germplasm collection provides a rich genetic base for developing superior hybrid seeds. This scientific foundation allows for continuous innovation and the creation of a "dream-product basket."

Nath Bio-Genes differentiates itself through a robust, research-driven product development process that creates customized seeds, supported by an extensive and deeply entrenched distribution network across India.

• Core Crop Performance: Growth in FY26 was primarily driven by the company's core crops.

• Cotton (Bt): Volume grew by 22.35% to 1.38 million packets, with value growing even faster at 28%. The new "Sanket Jumbo" variant was well-accepted, and the average selling price increased from ₹275 to ₹293 per kg.

• Paddy: Showed exceptional growth with a 25% increase in volume and a 37% increase in value.

• Maize: Was the highest growth crop, with volume up 54% and value up 78%. It now contributes 10.72% to the company's total revenue.

• Revenue Mix Concentration: The focus on core crops has been successful. The combined revenue share of Cotton and Paddy increased from 52% in FY25 to 58% in FY26, indicating a strategic shift towards its strongest segments.

• Segmental Weakness: Not all segments performed well.

• Vegetable Seeds: Experienced a 15% decline in volume and a 10% decline in value. However, a 6% increase in average realization (from ₹1,178 to ₹1,244 per kg) partially offset the volume drop.

• PNS (Plant Nutrition & Soil Health): Saw a significant contraction with a 19% decline in volume and a 17% decline in value, attributed to export restrictions from China. The company expects this situation to normalize.

The company's growth is being propelled by strong performance in its key Cotton, Paddy, and Maize segments, which has more than compensated for declines in the Vegetable Seeds and PNS businesses.

• International Expansion: The company has achieved a significant milestone in its international business. In FY26, its collaboration in Uzbekistan contributed ₹15 crore to the top line for the first time, signaling a new and potentially scalable revenue stream.

• Product Innovation and Premiumization: There is a clear opportunity to drive growth through new products and higher price points. The successful launch and market acceptance of the "Sanket Jumbo" cotton seed demonstrates the company's ability to innovate.

• Increasing Average Selling Price (ASP): The company has demonstrated pricing power. The ASP for Field Crops has risen from ₹128/kg in FY18 to ₹293/kg in FY26, and for Vegetables, it has increased from ₹480/kg to ₹1,244/kg in the same period. This trend presents an ongoing opportunity to enhance revenue and margins.

Key opportunities for future growth lie in expanding into new international markets, continuing to launch innovative and value-added products, and leveraging brand strength to command higher selling prices.

• Gross Margin Contraction: The company's Gross Margin experienced a sharp decline, falling to 56% in FY26 from 63% in FY25. This indicates a significant increase in the cost of goods sold relative to revenue.

• EBITDA Margin Decline: The pressure on gross margin flowed through to operating profitability. The EBITDA Margin contracted to 12% in FY26 from 14% in FY25. Historical data shows this is part of a longer-term trend, with margins declining from a high of 22% in FY21.

• Net Profit Margin Erosion: Consequently, the adjusted PAT Margin also decreased, falling to 9% in FY26 from 11% in FY25. The flat EBITDA on a 19% revenue increase clearly illustrates the impact of rising costs on overall profitability.

The company is facing significant margin pressure across its operations, with rising costs eroding the benefits of strong top-line growth and leading to lower profitability ratios.

• Margin Compression: The most immediate financial risk is the continued erosion of margins. If the trend of declining Gross, EBITDA, and PAT margins persists, it will severely impact the company's ability to generate profits and shareholder value, even if revenue continues to grow.

• Geopolitical and Trade Risks: The 17% revenue decline in the PNS segment due to "China export restrictions" highlights the company's vulnerability to external trade policies and geopolitical events. This poses a risk to segments reliant on international supply chains or markets.

• Working Capital Management: The substantial year-over-year increase in inventory levels (up 34%) could pose a risk. High inventory ties up capital and increases the risk of obsolescence or write-downs, while the sharp rise in trade payables could signal pressure on cash flows.

• Forward-Looking Statements: The company itself acknowledges risks in its forward-looking statements, including potential impacts from government actions, local political or economic developments, and technological changes that could cause actual results to differ from expectations.

Key risks facing the company include persistent profitability pressures from margin compression, exposure to international trade disruptions, and potential challenges related to effective working capital management.

• Leadership Team: The company is led by an experienced team, including Mr. Nandkishor Kagliwal as Chairman and Mr. Satish Kagliwal as Managing Director. Key functional heads include Mr. Amol Gupta (CFO), Dr. V. N. Kulkarni (Head – R & D), and Mr. K. Reddy (Head – Supply Chain).

• New International Revenue Stream: A major development is the successful entry into the Uzbekistan market. This collaboration generated its first-ever ₹15 crore in revenue in FY26, marking a landmark achievement in the company's international expansion strategy.

• Successful Product Launch: The "Sanket Jumbo" cotton seed has been well-accepted in the market. This serves as a positive indicator of the company's R&D effectiveness and its ability to successfully commercialize new products that meet farmer demands.

Significant business updates include the establishment of a new international revenue stream from Uzbekistan and the successful market adoption of new, innovative product variants.